Xiaochuan Ma

Prof. Xiaochuan Ma


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in NanoImpact
Verified
Journal Article
Closed access
YSYing Shi
Ying Shi
XMXiaochuan Ma
Xiaochuan Ma
GFGe Fang
Ge Fang
XTXin Tian
Xin Tian
CGCuicui Ge
Cuicui Ge

17 May 2017 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
XFXu Fang
Xu Fang
YWYaling Wang
Yaling Wang
XMXiaochuan Ma
Xiaochuan Ma
YLYingying Li
Yingying Li
ZZZhaolei Zhang
Zhaolei Zhang
JLJian Liu
Jian Liu
Peptide-templated Au nanoclusters have been developed with features of mitochondria-targeting and high efficacy in tumor cell ablation by the elevated ROS for radiosensitization.

Verified
Journal Article
Open access
PDF file
YSYe Shen
Ye Shen
KPKefeng Pu
Kefeng Pu
KZKexiao Zheng
Kexiao Zheng
XMXiaochuan Ma
Xiaochuan Ma
JQJingyi Qin
Jingyi Qin
JLJiong Li
Jiong Li
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies, and thus better understanding of its molecular pathology is crucial for us to devise more effective treatment of this deadly disease. As cancer cell line remains a convenient starting point for discovery and proof-of-concept studies, here we report the miRNA expression characteristics of two cell lines, MIA PaCa-2 and PANC-1, and discovered three miRNAs (miR-7-5p, let-7d, and miR-135b-5p) that are involved in cancer stem cells (CSCs) suppression. After transfection of each miRNA’s mimic into PANC-1 cells which exhibits higher stemness feature than MIA-PaCa-2 cells, partial reduction of CSC surface markers and inhibition of tumor sphere formation were observed. These results enlighten us to consider miRNAs as potential therapeutic agents for pancreatic cancer patients via specific and effective inhibition of CSCs.

1 December 2020 in Nano Today
Verified
Journal Article
Closed access
XMXiaochuan Ma
Xiaochuan Ma
SLSangyun Lee
Sangyun Lee
XFXingshu Fei
Xingshu Fei
GFGe Fang
Ge Fang
THTien Huynh
Tien Huynh
RZRuhong Zhou
Ruhong Zhou

3 July 2025 in International Immunopharmacology
Verified
Journal Article
Closed access
JXJing Xu
Jing Xu
XYXueting Yang
Xueting Yang
KPKefeng Pu
Kefeng Pu
QZQingyi Zhang
Qingyi Zhang
QWQichun Wei
Qichun Wei
ZHZhixing He
Zhixing He

1 May 2025 in Chemistry of Materials
Verified
Journal Article
Closed access
YCYanhua Chen
Yanhua Chen
YHYiran He
Yiran He
MJMin Jiang
Min Jiang
YSYe Shen
Ye Shen
XZXuewen Zheng
Xuewen Zheng
KPKefeng Pu
Kefeng Pu